An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. - Wikidata - awgldk - TriplyDB

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

http://www.wikidata.org/entity/Q30511948

about

Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.Effect of DOTS Treatment on Vitamin D Levels in Pulmonary Tuberculosis.Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.Metabolism of 20-hydroxyvitamin D3 by mouse liver microsomes Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.Impaired vitamin D metabolism in CKD Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia Hydroxylation of 20-hydroxyvitamin D3 by human CYP3A4.Vitamin d: pharmacokinetics and safety when used in conjunction with the pharmaceutical drugs used in cancer patients: a systematic review.Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry.Epilepsy treatment by sacrificing vitamin D.Simultaneous quantification of 25-hydroxyvitamin D3-3-sulfate and 25-hydroxyvitamin D3-3-glucuronide in human serum and plasma using liquid chromatography-tandem mass spectrometry coupled with DAPTAD-derivatization.Vitamin D and spinal cord injury: should we care?The Effects of First-Line Anti-Tuberculosis Drugs on the Actions of Vitamin D in Human Macrophages.CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.Evaluation of vitamin D levels in Indian children with intrathoracic tuberculosis Vitamin D and drug-metabolising enzymes.Sunlight exposure is just one of the factors which influence vitamin D status.Identification of ω- or (ω-1)-Hydroxylated Medium-Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity.The half-life of 25(OH)D after UVB exposure depends on gender and vitamin D receptor polymorphism but mainly on the start level.Regulation of vitamin D metabolism following disruption of the microbiota using broad spectrum antibiotics.CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract.The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency.

P2860

Q33610642-A3D9855C-5873-4095-9B27-2327FFF01047 Q33741505-317BFB02-5C9F-41E8-9979-596E78C6EC25 Q33954224-94460BF5-5E47-49A7-8F2F-4A8FE4FE0067 Q34332527-F64D7047-D570-4A2D-8968-0673577B859A Q34455184-F107C43F-0959-491E-957C-0DDD092CBCB2 Q36545257-09D6B889-A015-4F46-9B01-C1095DF352FF Q36618692-BC08F81A-E9ED-4B1F-BC35-E66FA057D61B Q36668070-62A316B7-59AF-42C9-A5A5-BF6D8064AEEC Q36721536-533E03CC-F717-4A85-9501-1FA98FBA36FA Q36767930-496B3B0E-E2F1-43A0-BE61-AE6401E76919 Q37061744-AAF6FFAB-CBF4-4663-9C6D-31CBD6D90FC2 Q37065755-72F17D94-D8F3-4765-83D1-F0CDBFFB9D1B Q38205010-A76BFDE2-A3E4-4607-99A4-48E4BF14D2E8 Q38373794-632216CE-1AD8-45A7-8848-8A9EF64D410B Q38958818-960ECBCF-F377-4C32-8B5D-AD984C4223FD Q39006303-5C00FAA7-C88B-41D6-AEAB-2684F717690C Q39247900-A3F6BBB1-5C51-4B35-943D-B868C1158A79 Q40563423-E87DEFA6-47CF-4220-B2DC-7C95A1257971 Q41640652-E27C5AC6-A8DD-4801-9B69-E141CC9392D3 Q42416797-11480541-5C8D-4E84-B54F-8EE9DE6F2B2C Q47247668-4CEDC4AB-02F2-456C-994E-CAB4D05BD5D5 Q47582208-E6E70E42-99EC-415B-91EB-5E84329F6FA1 Q47649551-4B73AD66-1F7E-4C84-8FFB-0AE976C619EC Q47769645-6C91ABB1-378D-4C63-BA65-175D933874FF Q49833498-11537BF7-389C-49E8-BE71-FA4CC222C70B Q51092138-D539B92F-46DE-4CC2-A8C8-A16B3BB9598D Q52691643-68B70C72-837B-4DB1-B941-5E157D174E23 Q55455498-FFB50BFE-3B66-4495-883D-513D837F6AB7

P2860

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

http://www.wikidata.org/entity/Q30511948

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@ast

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@en

type

label

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@ast

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@en

prefLabel

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@ast

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@en

P1433

Q30511948-7F2EA889-0A46-4CEA-9465-E54ACE8548D3

P1476

Q30511948-CA3F0E02-04F3-4539-97AE-021963066BA7

P2093

Q30511948-1657A165-5CC4-41FB-85E0-C65F8FDC438A

Q30511948-1A92CEB1-2C51-4648-B0B2-0C16933EFC47

Q30511948-243D3406-9F9E-40FC-BA13-0A11577755BC

Q30511948-40D521DB-288E-4D9C-875F-9E44911475BC

Q30511948-5103C7B7-DDB1-4A6F-BA0E-8D8421103C21

Q30511948-55BA5904-DD79-457B-880A-F92D9CCB405A

Q30511948-612E16FB-9C41-4F78-9364-6F5897913DA8

Q30511948-8243A7D2-AC49-4A73-A688-6C1A3689F606

Q30511948-8A4051BA-9C26-4638-AFD8-99076D44E47E

Q30511948-9412422F-F648-4A5D-A0C7-7D0484E9C1F0

P2860

Q30511948-04FA0E6E-5EA1-4C2A-ADE6-A5AADC937EE1

Q30511948-05F594BA-2680-4B6B-AFBA-F1C6DED05582

Q30511948-0FE8FFB1-9436-44C3-A70C-F4A67AA65FE7

Q30511948-12BDC253-9CA1-4A5E-9E2E-A1B5581DA84D

Q30511948-1B56A7D0-EDC7-40F4-86A6-80DE3F10693C

Q30511948-2214B256-AB8A-4DE6-AA75-EB701EF5D24F

Q30511948-280BCC73-506B-4D24-9F6D-548E4A11374B

Q30511948-2CF24E08-96A4-455B-8710-5E0229AA68F8

Q30511948-33C54682-4257-4A61-890B-0D8FA3BC51C7

Q30511948-3C109C15-93A6-4C17-B957-B88C3B6EF9DB

P304

Q30511948-21620CC3-9B53-4860-B642-E2035C3F49F1

P31

Q30511948-BDB46603-2BDA-4AC3-82E2-7DF440306AFF

P356

Q30511948-1A505533-DB47-47F8-BCF9-D09194FDD404

P433

Q30511948-E5CD2176-CF41-4735-99B7-216EB249DD51

P478

Q30511948-015D0B4C-8B1E-42A5-9DBE-84F8E5CBCED1

P577

Q30511948-BAE7E829-547A-4E48-B034-E37590A335F3

P5875

Q30511948-745CCBA9-07B4-4EA1-806E-FC2B1E9CEADF

P698

Q30511948-29D3C9EA-B059-4F6B-A86F-E36A76545DC0

P921

Q30511948-916302e0-a6c3-4fe6-8896-7cb60ba1948f

Q30511948-9B7C6EA5-8082-4F6A-9207-392B95D928C6

P932

Q30511948-0EB6F2DC-1685-437E-8FD5-13BB8E4F85F4

P356

P1433

Molecular Pharmacology

P1476

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

@en

P2093

Connie L Davis

http://www.w3.org/2001/XMLSchema#string

David Blough

http://www.w3.org/2001/XMLSchema#string

Kenneth E Thummel

http://www.w3.org/2001/XMLSchema#string

Leslie J Dickmann

http://www.w3.org/2001/XMLSchema#string

Mary F Hebert

http://www.w3.org/2001/XMLSchema#string

Michele Scian

http://www.w3.org/2001/XMLSchema#string

Sidney D Nelson

http://www.w3.org/2001/XMLSchema#string

Takanori Hashizume

http://www.w3.org/2001/XMLSchema#string

Tauri Senn

http://www.w3.org/2001/XMLSchema#string

Thomas A Baillie

http://www.w3.org/2001/XMLSchema#string

P2860

CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

Vitamin D deficiency

Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1

Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24

Vitamin D: metabolism.

The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3).

1alpha-Hydroxylase and the action of vitamin D.

Effect of rifampicin and isoniazid on vitamin D metabolism.

Enzymes involved in the activation and inactivation of vitamin D.

P304

498-509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/MOL.111.076356

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51977720

http://www.w3.org/2001/XMLSchema#string

P698

22205755

http://www.w3.org/2001/XMLSchema#string

P921

P932

3310418

http://www.w3.org/2001/XMLSchema#string